Gsa Capital Partners LLP Aim Immuno Tech Inc. Transaction History

Gsa Capital Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$1.93 - $2.39 $144,344 - $178,748	-74,790 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$1.88 - $2.82 $108,556 - $162,835	57,743 Added 338.73%	74,790 $170,000
Q4 2020 Feb 03, 2021	SELL	$1.68 - $2.45 $132,227 - $192,832	-78,707 Reduced 82.2%	17,047 $31,000
Q3 2020 Nov 06, 2020	BUY	$1.77 - $3.88 $169,484 - $371,525	95,754 New	95,754 $206,000

8.97M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $12M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.